表紙
市場調查報告書
商品編碼
961325

小鼠模型的全球市場(約2025年):小鼠類型(近交/變異)/技術(CRISPR / TALEN / ZFN)/用途(癌症/糖尿病/免疫系統)/服務(繁殖/冷凍保存/基因檢測)□保養品/地區

Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products, Region-Global Forecast to 2025

出版日期: | 出版商: MarketsandMarkets | 英文 253 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球小鼠模型市場預計將以6.4%的複合年增長率增長,從2020年的14億美元增長到2025年的19億美元。諸如製藥和生物製藥行業的研發成本增加,小鼠臨床試驗(MCT)對更可預測的結果的影響增加以及鼠標模型的持續創新等因素正在推動市場的增長。另一方面,諸如動物保護和福利法規之類的因素可能會阻礙市場的進一步增長。

按小鼠類型,基因工程小鼠部分顯示出快速的增長。諸如在各種研究領域中的使用,新的CRISPR技術,不斷引入的新模型以及對個性化醫學的日益關注等因素推動著該領域的發展。就技術而言,CRISPR/Cas9領域佔有最大佔有率。 CRISPR是市場上使用最廣泛的技術,由於其易於設計,高效和相對較低的成本,因此需求不斷增長。

本報告調查了全球小鼠模型市場,定義和概述了市場,分析了COVID-19和其他市場影響因素,相關法律法規,臨床試驗趨勢以及市場規模趨勢和預測。小鼠類型,服務,技術,應用,口腔護理產品,地區/主要國家等,按類別細分,競爭環境,主要公司的概況等。

第1章簡介

第2章調查方法

第3章執行摘要

第4章重要注意事項

第5章市場概述

  • 市場動態
    • 市場增長因素
    • 限制
    • 市場機會
    • 挑戰
    • 威脅
  • COVID-19的影響

第6章監管評估:按地區

第7章臨床試驗評估

第8章市場分析/預測:按小鼠類型

  • 近交小鼠
  • 變異小鼠
  • 轉基因小鼠
  • 混合/先天小鼠
  • 有條件/手術修飾的小鼠
  • 自發突變的小鼠

第9章市場分析/預測:按服務

  • 繁殖
  • 冷凍保存
  • 隔離
  • 重新派生
  • 模型許可
  • 基因檢測
  • 其他

第10章市場分析/預測:按技術

  • CRISPR/CAS9
  • 微量注射
  • 胚胎幹細胞注射
  • 核移植
  • 其他技術
    • 精子介導的基因轉移(SMGT)
    • 病毒/載體介導的基因轉移
    • 脂質體介導的DNA/DNA電穿孔
    • Biolistec
    • TALEN □ ZFN

第11章市場分析/預測:按應用

  • 腫瘤學研究
  • 免疫/炎症研究
  • 內分泌代謝研究
    • 糖尿病研究
    • 其他內分泌代謝研究
  • 心血管研究
  • 中樞神經系統(CNS)研究
  • 基因研究
  • 傳染病研究
  • 其他

第12章市場分析/預測:按小鼠護理產品分類

  • 籠子
  • 飼料
  • 其他

第13章市場分析/預測:按地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 其他
  • 其他地區
    • 拉丁美洲
    • 中東/非洲

第14章競爭情況

  • 市場排名分析

第15章公司評估矩陣/公司簡介

  • 概述
  • 企業評估矩陣
  • 市場評估框架
  • 競爭情景
  • 公司簡介
    • CHARLES RIVER LABORATORIES INTERNATIONAL
    • THE JACKSON LABORATORY
    • ENVIGO
    • GENOWAY
    • TACONIC BIOSCIENCES, INC.
    • JANVIER LABS
    • HARBOUR BIOMED
    • TRANS GENIC, INC.
    • INGENIOUS TARGETING LABORATORY
    • POLYGENE
    • GVK BIO
    • CYAGEN BIOSCIENCES
    • CROWN BIOSCIENCE INC. (A SUBSIDIARY OF JSR CORPORATION)
    • TRANSCURE BIOSERVICES
    • OZGENE PTY LTD
    • THE ANDERSONS, INC.
    • FENGSHI GROUP
    • ALLENTOWN, LLC
    • INNOVIVE
    • LAB PRODUCTS, INC

第16章附錄

目錄
Product Code: BT 2192

Title:
Mice Model Market
by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecast to 2025.

"Increasing implication of mouse clinical trials (MCTs) and ongoing innovation in mice models are set to drive the mice model market.''

The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. The major factors driving the growth of this market are the Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes and ongoing innovations in mice models are driving the growth of the global mice model industry. However, Implementation of laws and regulations for animal protection and welfare has enforced restrictive practices and bans on the use of animals for different purposes that may restrict the growth of this market to a certain extent.

"By mice type, the genetically engineered mice accounted for the fastest-growing segment of the mice model market."

Genetically engineered mice segment is anticipated to be the fastest-growing due to the widespread use of these mice in diverse research areas, the emerging CRISPR technology, increasing focus on personalized medicine with the continuous introduction of new models

"By service, the breeding segment accounted for the largest share of the mice model market."

The breeding segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing demand for mice models for drug discovery and development and the subsequent increase in the demand for personalized medicines.

"Oncology segment expected to grow at the fastest growth rate during the forecast period."

Based on application, the mice model market has been segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. The endocrine disease studies segment is further segmented into diabetes and other endocrine metabolic disease. The oncology segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.

"By technology type, CRISPR/Cas9 accounted for the largest share of the mice model market"

CRISPR is the most widely used technology in the mice model market and contributed to the largest share of the mice model market in 2020. Ease of design, high efficiency, and relatively lower cost have increased the demand for CRISPR-customized mice models.

"By mice care product, cages segment accounted for the largest share of the mice model market"

Based on mice care products, the mice model market has been segmented into cages, feed, bedding, and other products (gnotobiotic equipment, water systems, and accessories). The cages segment accounted for the largest share of the mice model market. This can be attributed to the availability of a wide range of cages designed for specific research needs and the higher cost of cages compared to other care products.

"Asia Pacific: The fastest-growing region in the mice model market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.

"North America: The largest share of the drug discovery services market."

North America, which includes the US and Canada, accounted for the largest share of the mice model market. The large share of the North America region can be attributed to the presence of major players operating in the mice model market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 80%, Demand Side-20%
  • By Designation- Executives- 25%, CXOs- 20%, Managers - 55%
  • By Region- North America - 50%, Europe - 20%, APAC - 20%, RoW- 10%

The mice model market is dominated by a few globally established players such as Charles River Laboratories (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure Bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI GROUP (China), Ozgene Pty Ltd. (Australia), and Harbour Biomed (US).

Research Coverage:

The report segments the mice model market based on region (North America, Asia Pacific, Europe, and RoW), mice type (inbred mice, outbred mice, conditioned/surgically modified mice, hybrid/congenic mice, genetically engineered mice, and spontaneous mutant mice), service (breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services ((surgical, line rescue, and in vivo pharmacology services)), application (oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies), technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (virus/vector-mediated gene transfer, and TALENs & ZFNs)) and mice care product (cages, feed, bedding and other products (gnotobiotic equipment, water systems, and accessories)), Company type (Tier 1, tier 2, Tier3 mice providers). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the mice model market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the mice model market and provides them information on key market drivers, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 1 BREAKDOWN OF PRIMARIES: MICE MODEL MARKET
    • 2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
      • 2.1.3.1 Data triangulation
    • FIGURE 2 DATA TRIANGULATION METHODOLOGY
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 4 MICE MODEL MARKET SIZE (USD MILLION)
    • FIGURE 5 MICE MODEL MARKET: GROWTH RATE OF TOP COMPANIES (2018-2019)
    • FIGURE 6 MICE MODEL MARKET: FINAL CAGR PROJECTIONS (2020-2025)
    • FIGURE 7 MICE MODEL MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
  • 2.3 INDUSTRY INSIGHTS
  • 2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 8 MICE MODEL MARKET SHARE, BY MICE TYPE, 2019
    • FIGURE 9 MICE MODEL MARKET SHARE, BY SERVICE, 2019
    • FIGURE 10 MICE MODEL MARKET, BY APPLICATION: MARKET RANKING OF SEGMENTS, BY MARKET SIZE
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE MICE MODEL MARKET

4 PREMIUM INSIGHTS

  • 4.1 MICE MODEL MARKET OVERVIEW
    • FIGURE 12 GROWTH IN NUMBER OF PHARMACEUTICAL R&D ACTIVITIES AND GROWING DEMAND FOR PERSONALIZED MEDICINE WILL FAVOR MARKET GROWTH
  • 4.2 ASIA PACIFIC: MICE MODEL MARKET SHARE, BY MICE CARE PRODUCT AND BY COUNTRY (2019)
    • FIGURE 13 THE CAGES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
  • 4.3 MICE MODEL MARKET, BY MICE TYPE
    • FIGURE 14 INBRED MICE SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
  • 4.4 MICE MODEL MARKET SHARE, BY SERVICE, 2020 VS. 2025
    • FIGURE 15 IN TERMS OF SERVICE, BREEDING HOLDS THE LARGEST SHARE OF THE MARKET
  • 4.5 MICE MODEL MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 16 ONCOLOGY STUDIES SEGMENT ACCOUNTS FOR THE LARGEST MARKET SHARE

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Growing usage of mice models in virology and infectious diseases
      • 5.2.1.2 Increasing implications of mouse clinical trials (MCTs) for more predictive outcomes
      • 5.2.1.3 Increasing demand for personalized medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulations and laws for the ethical use of animals in research
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 CRISPR emerging as a powerful tool in biomedical research
      • 5.2.3.2 Rising demand for humanized mice models
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Development of alternative animal testing methods
    • 5.2.5 THREATS
      • 5.2.5.1 Growing use of rat models
  • 5.3 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE MICE MODEL MARKET

6 REGULATORY ASSESSMENT

  • 6.1 INTRODUCTION
  • 6.2 NORTH AMERICA
  • 6.3 EUROPE
  • 6.4 CHINA
  • 6.5 JAPAN
  • 6.6 INDIA
  • 6.7 AUSTRALIA
  • 6.8 BRAZIL

7 CLINICAL STUDIES ASSESSMENT

  • 7.1 INTRODUCTION
  • 7.2 CLINICAL STUDIES
    • FIGURE 18 CLINICAL STUDIES USING MICE MODELS, BY INDICATION (2017 ONWARDS)
    • FIGURE 19 CLINICAL STUDIES USING MICE MODELS, BY COMPLETION (2017 ONWARDS)
    • TABLE 1 INDICATIVE LIST OF CLINICAL STUDIES CONDUCTED USING MICE MODELS

8 MICE MODEL MARKET, BY MICE TYPE

  • 8.1 INTRODUCTION
    • TABLE 2 MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
  • 8.2 INBRED MICE
    • 8.2.1 INCREASING APPLICATIONS OF INBRED MICE LIKELY TO DRIVE THE MARKET
    • TABLE 3 INBRED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 4 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 5 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 6 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 7 ROW: INBRED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 OUTBRED MICE
    • 8.3.1 GENETIC DIVERSITY OFFERED BY OUTBRED MICE TO BOOST THE MARKET
    • TABLE 8 OUTBRED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 9 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 10 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 11 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 12 ROW: OUTBRED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 GENETICALLY ENGINEERED MICE
    • 8.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINES TO DRIVE DEMAND
    • TABLE 13 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 14 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 15 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 16 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 17 ROW: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 HYBRID/CONGENIC MICE
    • 8.5.1 INCREASING USE OF CONGENIC MICE IN BIOMEDICAL RESEARCH CONTRIBUTES TO MARKET GROWTH
    • TABLE 18 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 19 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 20 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 22 ROW: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.6 CONDITIONED/SURGICALLY MODIFIED MICE
    • 8.6.1 INCREASING INCIDENCE OF METABOLIC DISEASES TO DRIVE THE MARKET
    • TABLE 23 CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 24 NORTH AMERICA: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 25 EUROPE: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 27 ROW: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.7 SPONTANEOUS MUTANT MICE
    • 8.7.1 ADVANCEMENTS IN BIOMEDICAL RESEARCH AND INCREASING APPLICATIONS TO BOOST DEMAND
    • TABLE 28 SPONTANEOUS MUTANT MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 29 NORTH AMERICA: SPONTANEOUS MUTANT MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 30 EUROPE: SPONTANEOUS MUTANT MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: SPONTANEOUS MUTANT MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 32 ROW: SPONTANEOUS MUTANT MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)

9 MICE MODEL MARKET, BY SERVICE

  • 9.1 INTRODUCTION
    • TABLE 33 MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
  • 9.2 BREEDING
    • 9.2.1 GROWING NUMBER OF MICE MODEL STUDIES TO BOOST THE MARKET
    • TABLE 34 BREEDING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 35 NORTH AMERICA: BREEDING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 36 EUROPE: BREEDING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: BREEDING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 38 ROW: BREEDING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 CRYOPRESERVATION
    • 9.3.1 NEED FOR PRESERVATION OF NOVEL MICE MODELS LIKELY TO DRIVE THE MARKET
    • TABLE 39 CRYOPRESERVATION SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 40 NORTH AMERICA: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 41 EUROPE: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 43 ROW: CRYOPRESERVATION SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 QUARANTINE
    • 9.4.1 RISING DEMAND FOR GERM-FREE MICE TO BOOST MARKET
    • TABLE 44 QUARANTINE SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 45 NORTH AMERICA: QUARANTINE SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 46 EUROPE: QUARANTINE SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: QUARANTINE SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 48 ROW: QUARANTINE SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.5 REDERIVATION
    • 9.5.1 STRINGENT QUALITY ASSURANCE STANDARDS TO BOOST THE MARKET
    • TABLE 49 REDERIVATION SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 50 NORTH AMERICA: REDERIVATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 51 EUROPE: REDERIVATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 52 ASIA PACIFIC: REDERIVATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 53 ROW: REDERIVATION SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.6 MODEL IN-LICENSING
    • 9.6.1 INCREASING INDEPENDENT RESEARCH BY SCIENTIFIC COMMUNITY LIKELY TO FUEL MARKET GROWTH
    • TABLE 54 MODEL IN-LICENSING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 56 EUROPE: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 58 ROW: MODEL IN-LICENSING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.7 GENETIC TESTING
    • 9.7.1 RISING DEMAND FOR TRANSGENIC MICE LIKELY TO DRIVE THE MARKET
    • TABLE 59 GENETIC TESTING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 60 NORTH AMERICA: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 61 EUROPE: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 63 ROW: GENETIC TESTING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.8 OTHER SERVICES
    • TABLE 64 OTHER SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 65 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 66 EUROPE: OTHER SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 68 ROW: OTHER SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)

10 MICE MODEL MARKET, BY TECHNOLOGY

  • 10.1 INTRODUCTION
    • TABLE 69 MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 70 MICE MODEL MARKET, BY OTHER TECHNOLOGIES, 2018-2025 (USD MILLION)
  • 10.2 CRISPR/CAS9
    • 10.2.1 ADVANTAGES OF CRISPR LIKELY TO BOOST SEGMENT GROWTH
    • TABLE 71 MICE MODEL MARKET SIZE FOR CRISPR TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 72 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 73 EUROPE: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 75 ROW: CRISPR TECHNOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.3 MICROINJECTION
    • 10.3.1 HIGH SUCCESS RATE AND LACK OF CONSTRAINTS TO PROPEL SEGMENT
    • TABLE 76 MICE MODEL MARKET SIZE FOR MICROINJECTION TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 77 NORTH AMERICA: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 78 EUROPE: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 80 ROW: MICROINJECTION TECHNOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.4 EMBRYONIC STEM CELL INJECTION
    • 10.4.1 GROWING DEMAND FOR TARGETED MICE MODELS TO PROPEL THE MARKET
    • TABLE 81 MICE MODEL MARKET SIZE FOR EMBRYONIC STEM CELL INJECTION TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 82 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 83 EUROPE: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 85 ROW: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.5 NUCLEAR TRANSFER
    • 10.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE IS LIKELY TO DRIVE MARKET GROWTH
    • TABLE 86 MICE MODEL MARKET SIZE FOR NUCLEAR TRANSFER TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 87 NORTH AMERICA: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 88 EUROPE: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 90 ROW: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.6 OTHER TECHNOLOGIES
    • TABLE 91 MICE MODEL MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 92 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 93 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 95 ROW: OTHER TECHNOLOGIES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 10.6.1 SPERM-MEDIATED GENE TRANSFER
    • TABLE 96 MICE MODEL MARKET SIZE FOR SPERM-MEDIATED GENE TRANSFER TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 10.6.2 VIRUS/VECTOR-MEDIATED GENE TRANSFER
    • TABLE 97 MICE MODEL MARKET SIZE FOR VIRUS/VECTOR-MEDIATED GENE TRANSFER TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 10.6.3 LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA
    • TABLE 98 MICE MODEL MARKET SIZE FOR LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 10.6.4 BIOLISTICS
    • TABLE 99 MICE MODEL MARKET SIZE FOR BIOLISTICS TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)
    • 10.6.5 TALENS AND ZFNS
    • TABLE 100 MICE MODEL MARKET SIZE FOR TALENS AND ZFNS TECHNOLOGY, BY REGION, 2018-2025 (USD MILLION)

11 MICE MODEL MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 101 MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 102 MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
  • 11.2 ONCOLOGY STUDIES
    • 11.2.1 INCREASING IMPLICATIONS OF MICE MODELS IN STUDY OF CANCER TO DRIVE THE MARKET
    • TABLE 103 MICE MODEL MARKET SIZE FOR ONCOLOGY STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 104 NORTH AMERICA: ONCOLOGY STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 105 EUROPE: ONCOLOGY STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: ONCOLOGY STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 107 ROW: ONCOLOGY STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.3 IMMUNOLOGY AND INFLAMMATION STUDIES
    • 11.3.1 DEVELOPMENT OF ADVANCED MODELS FOR HUMAN IMMUNOLOGY STUDIES TO BOOST MARKET GROWTH
    • TABLE 108 MICE MODEL MARKET SIZE FOR IMMUNOLOGY AND INFLAMMATION STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 109 NORTH AMERICA: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 110 EUROPE: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 112 ROW: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.4 ENDOCRINE METABOLIC STUDIES
    • 11.4.1 GROWING PREVALENCE OF METABOLIC DISORDERS LIKELY TO DRIVE THE MARKET
    • TABLE 113 MICE MODEL MARKET SIZE FOR ENDOCRINE METABOLIC STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 114 NORTH AMERICA: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 115 EUROPE: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 117 ROW: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 11.4.2 DIABETES STUDIES
    • TABLE 118 MICE MODEL MARKET SIZE FOR DIABETES STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 119 NORTH AMERICA: DIABETES STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 120 EUROPE: DIABETES STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: DIABETES STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 122 ROW: DIABETES STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 11.4.3 OTHER ENDOCRINE METABOLIC STUDIES
    • TABLE 123 MICE MODEL MARKET SIZE FOR OTHER ENDOCRINE METABOLIC STUDIES, BY REGION, 2018-2025 (USD MILLION)
  • 11.5 CARDIOVASCULAR STUDIES
    • 11.5.1 RISING BURDEN OF CARDIOVASCULAR DISORDERS HAS BOOSTED OVERALL R&D ACTIVITY
    • TABLE 124 MICE MODEL MARKET SIZE FOR CARDIOVASCULAR STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 125 NORTH AMERICA: CARDIOVASCULAR STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 126 EUROPE: CARDIOVASCULAR STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: CARDIOVASCULAR STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 128 ROW: CARDIOVASCULAR STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.6 CENTRAL NERVOUS SYSTEM (CNS) STUDIES
    • 11.6.1 INCREASING FOCUS ON MICE MODEL DEVELOPMENT FOR CNS DISORDERS TO PROPEL MARKET
    • TABLE 129 MICE MODEL MARKET SIZE FOR CENTRAL NERVOUS SYSTEM STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 130 NORTH AMERICA: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 131 EUROPE: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 133 ROW: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.7 GENETIC STUDIES
    • 11.7.1 ADVANCEMENTS IN GENE EDITING TECHNIQUES TO DRIVE THE MARKET
    • TABLE 134 MICE MODEL MARKET SIZE FOR GENETIC STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 135 NORTH AMERICA: GENETIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 136 EUROPE: GENETIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: GENETIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 138 ROW: GENETIC STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.8 INFECTIOUS DISEASE STUDIES
    • 11.8.1 INCREASING OUTBREAKS OF INFECTIOUS DISEASES TO PROPEL DRUG DEVELOPMENT ACTIVITIES
    • TABLE 139 MICE MODEL MARKET SIZE FOR INFECTIOUS DISEASE STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 140 NORTH AMERICA: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 141 EUROPE: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 143 ROW: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.9 OTHER DISEASE STUDIES
    • TABLE 144 MICE MODEL MARKET SIZE FOR OTHER DISEASE STUDIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 145 NORTH AMERICA: OTHER DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 146 EUROPE: OTHER DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: OTHER DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 148 ROW: OTHER DISEASE STUDIES MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)

12 MICE MODEL MARKET, BY MICE CARE PRODUCT

  • 12.1 INTRODUCTION
    • TABLE 149 MICE CARE PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 12.2 CAGES
    • 12.2.1 DEVELOPMENT OF DIFFERENT CAGE SYSTEMS TO DRIVE THE MARKET
    • TABLE 150 MICE CAGES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 151 NORTH AMERICA: MICE CAGES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 152 EUROPE: MICE CAGES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 153 ASIA PACIFIC: MICE CAGES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 154 ROW: MICE CAGES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 12.3 FEED
    • 12.3.1 PREFERENCE FOR HEALTHY AND POWERED DIET TO DRIVE THE MARKET
    • TABLE 155 MICE FEED MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 156 NORTH AMERICA: MICE FEED MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 157 EUROPE: MICE FEED MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: MICE FEED MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 159 ROW: MICE FEED MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 12.4 BEDDING
    • 12.4.1 ENVIRONMENTAL ENRICHMENT STRATEGY FOR WELFARE OF LABORATORY ANIMALS LIKELY TO BOOST MARKET GROWTH
    • TABLE 160 MICE BEDDING MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 161 NORTH AMERICA: MICE BEDDING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 162 EUROPE: MICE BEDDING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: MICE BEDDING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 164 ROW: MICE BEDDING MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 12.5 OTHER MICE CARE PRODUCTS
    • TABLE 165 OTHER MICE CARE PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 166 NORTH AMERICA: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 167 EUROPE: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 169 ROW: OTHER MICE CARE PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION) 147

13 MICE MODEL MARKET, BY REGION

  • 13.1 INTRODUCTION
    • FIGURE 20 MICE MODEL MARKET SNAPSHOT
    • TABLE 170 MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 13.2 NORTH AMERICA
    • FIGURE 21 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
    • TABLE 171 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 172 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 173 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 174 NORTH AMERICA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 176 NORTH AMERICA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 177 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 178 NORTH AMERICA: MICE MODEL MARKET, BY OTHER TECHNOLOGIES, 2018-2025 (USD MILLION)
    • TABLE 179 NORTH AMERICA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.2.1 US
      • 13.2.1.1 Government funding for life sciences research drives market growth in the US
      • 13.2.1.2 Rising production of monoclonal antibodies to augment use of mice models
    • TABLE 180 US: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 181 US: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 182 US: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 183 US: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 184 US: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 185 US: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 186 US: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.2.2 CANADA
      • 13.2.2.1 Growth in stem cell research activities expected to lead to expansion of mice model market
    • TABLE 187 CANADA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 188 CANADA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 189 CANADA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 190 CANADA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 191 CANADA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 192 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 193 CANADA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
  • 13.3 EUROPE
    • TABLE 194 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 195 EUROPE: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 196 EUROPE: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 197 EUROPE: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 198 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 199 EUROPE: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 200 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 201 EUROPE: MICE MODEL MARKET, BY OTHER TECHNOLOGIES, 2018-2025 (USD MILLION)
    • TABLE 202 EUROPE: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.3.1 GERMANY
      • 13.3.1.1 Germany accounted for the second-largest share of the European market
    • TABLE 203 GERMANY: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 204 GERMANY: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 205 GERMANY: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 206 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 207 GERMANY MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 208 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 209 GERMANY: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.3.2 FRANCE
      • 13.3.2.1 Increased investments in proteomics and genomics likely to fuel growth of mice models
    • TABLE 210 FRANCE: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 211 FRANCE: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 212 FRANCE: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 213 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 214 FRANCE: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 215 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 216 FRANCE: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.3.3 UK
      • 13.3.3.1 Increasing focus on cancer research in the UK is a key market growth driver
    • TABLE 217 UK: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 218 UK: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 219 UK: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 220 UK: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 221 UK: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 222 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 223 UK: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.3.4 REST OF EUROPE
      • 13.3.4.1 EU funding to support biomedical research
    • TABLE 224 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 225 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 226 REST OF EUROPE: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 227 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 228 REST OF EUROPE: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 229 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 230 REST OF EUROPE: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
  • 13.4 ASIA PACIFIC
    • FIGURE 22 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT
    • TABLE 231 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 232 ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 233 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 234 ASIA PACIFIC: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 235 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 236 ASIA PACIFIC: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 237 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 238 ASIA PACIFIC: MICE MODEL MARKET, BY OTHER TECHNOLOGIES, 2018-2025 (USD MILLION)
    • TABLE 239 ASIA PACIFIC: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.4.1 JAPAN
      • 13.4.1.1 Increasing focus on personalized diagnostics products to support market growth
    • TABLE 240 JAPAN: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 241 JAPAN: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 242 JAPAN: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 243 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 244 JAPAN: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 245 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 246 JAPAN: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.4.2 CHINA
      • 13.4.2.1 International alliances for R&D activities are driving the market
    • TABLE 247 CHINA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 248 CHINA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 249 CHINA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 250 CHINA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 251 CHINA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 252 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 253 CHINA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.4.3 INDIA
      • 13.4.3.1 Robust growth in biotech industry in India to boost the mice model market
    • TABLE 254 INDIA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 255 INDIA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 256 INDIA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 257 INDIA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 258 INDIA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 259 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 260 INDIA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.4.4 SOUTH KOREA
      • 13.4.4.1 Resolute R&D investment in drug development
    • TABLE 261 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 262 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 263 SOUTH KOREA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 264 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 265 SOUTH KOREA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 266 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 267 SOUTH KOREA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.4.5 REST OF ASIA PACIFIC
      • 13.4.5.1 Increase in animal research to boost the mice model market
    • TABLE 268 R0APAC: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 269 R0APAC: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 270 R0APAC: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 271 R0APAC: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 272 R0APAC: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 273 R0APAC: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 274 R0APAC: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
  • 13.5 REST OF THE WORLD
    • TABLE 275 ROW: MICE MODEL MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 276 ROW: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 277 ROW: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 278 ROW: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 279 ROW: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 280 ROW: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 281 ROW: MICE MODEL MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 282 ROW: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.5.1 LATIN AMERICA
      • 13.5.1.1 The growing pharmaceutical industry will propel drug development in Latin America
    • TABLE 283 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 284 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 285 LATIN AMERICA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 286 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 287 LATIN AMERICA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 288 LATIN AMERICA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)
    • 13.5.2 MIDDLE EAST & AFRICA
      • 13.5.2.1 Infrastructural development expected to contribute to the growth of the regional market
    • TABLE 289 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 290 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY SERVICE, 2018-2025 (USD MILLION)
    • TABLE 291 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MICE TYPE, 2018-2025 (USD MILLION)
    • TABLE 292 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 293 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018-2025 (USD MILLION)
    • TABLE 294 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MICE CARE PRODUCT, 2018-2025 (USD MILLION)

14 COMPETITIVE LANDSCAPE

  • 14.1 INTRODUCTION
  • 14.2 MARKET RANKING ANALYSIS
    • FIGURE 23 COMPANY RANKING IN THE MICE MODEL MARKET, 2019

15 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 15.1 OVERVIEW
  • 15.2 MICE MODEL MARKET: COMPANY EVALUATION MATRIX
    • 15.2.1 STARS
    • 15.2.2 EMERGING LEADERS
    • 15.2.3 PERVASIVE COMPANIES
    • 15.2.4 PARTICIPANTS
    • FIGURE 24 GLOBAL MICE MODEL MARKET: COMPANY EVALUATION MATRIX, 2019
  • 15.3 MARKET EVALUATION FRAMEWORK
    • TABLE 295 MARKET EVALUATION FRAMEWORK: PRODUCT DEVELOPMENT & LAUNCH IS THE MAJOR STRATEGY ADOPTED BY PLAYERS
  • 15.4 COMPETITIVE SCENARIO
    • 15.4.1 KEY PRODUCT LAUNCHES
    • 15.4.2 KEY ACQUISITIONS
    • 15.4.3 KEY COLLABORATIONS
    • 15.4.4 KEY SERVICE EXPANSIONS
  • 15.5 COMPANY PROFILES

(Business overview, Products offered, Recent developments, MNM view)**

    • 15.5.1 CHARLES RIVER LABORATORIES INTERNATIONAL
    • FIGURE 25 CHARLES RIVER LABORATORIES INTERNATIONAL: COMPANY SNAPSHOT (2019)
    • 15.5.2 THE JACKSON LABORATORY
    • FIGURE 26 THE JACKSON LABORATORY: COMPANY SNAPSHOT (2019)
    • 15.5.3 ENVIGO
    • 15.5.4 GENOWAY
    • FIGURE 27 GENOWAY: COMPANY SNAPSHOT (2019)
    • 15.5.5 TACONIC BIOSCIENCES, INC.
    • 15.5.6 JANVIER LABS
    • 15.5.7 HARBOUR BIOMED
    • 15.5.8 TRANS GENIC, INC.
    • FIGURE 28 TRANS GENIC, INC.: COMPANY SNAPSHOT (2019)
    • 15.5.9 INGENIOUS TARGETING LABORATORY
    • 15.5.10 POLYGENE
    • 15.5.11 GVK BIO
    • 15.5.12 CYAGEN BIOSCIENCES
    • 15.5.13 CROWN BIOSCIENCE INC. (A SUBSIDIARY OF JSR CORPORATION)
    • 15.5.14 TRANSCURE BIOSERVICES
    • 15.5.15 OZGENE PTY LTD
    • 15.5.16 THE ANDERSONS, INC.
    • FIGURE 29 THE ANDERSONS, INC.: COMPANY SNAPSHOT (2019)
    • 15.5.17 FENGSHI GROUP
    • 15.5.18 ALLENTOWN, LLC
    • 15.5.19 INNOVIVE
    • 15.5.20 LAB PRODUCTS, INC

*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 AVAILABLE CUSTOMIZATIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS 263